FibroBiologics to also present at the BIO CEO & Investor Conference. HOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinica ...
DOYLESTOWN, Pa. - Aprea Therapeutics, Inc. (NASDAQ: NASDAQ:APRE), a biopharmaceutical company with a market capitalization of $21.2 million focused on developing treatments targeting cancer cell ...
Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...
Curio Wellness, a cGMP-certified, vertically integrated cannabis company and market-leading innovator of health and wellness products, today announced the launch of their cultivation operations and ...
By injecting neat or semi-dilute products at the nozzle, the innovative Knight Smart-Inject system provides instant product ...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the German Federal Patent Court (Bundespatentgericht) has ruled in its favor in a patent dispute against SD Biosensor, ...
"The surge of trojan malware and fraud is top of mind in the mobile economy," said Tom Tovar, co-creator and CEO of Appdome. "We study more than 5 billion data points every week to understand how ...
Northstrive Biosciences announced an update for its obesity treatment candidates, EL-22 and EL-32, both aimed at optimizing fat loss while ...
Attendees will have the exclusive opportunity to experience live demonstrations of VeriQual’s identity verification and ...
Expanding the Possibilities of All-in-One LED Displays to Meet Diverse Needs BREA, Calif., Feb. 3, 2025 /PRNewswire/ -- ViewSonic Corp., a leading global provider of visual solutions, is unveiling the ...
Executive orders and other developments suggest changes are in store in the intellectual property (IP) sphere, but the exact shape of the changes ...
This week we speak with Scott McKeown, who is a shareholder at Wolf Greenfield and one of the leading U.S. PTAB practitioners ...